bpc 157 safety human trials BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 for athletes and injury
Description
not recommended

Safety & Contraindications Regulatory reality first: Retatrutide is investigational and not approved by the FDA or EMA for any indication
Current pharmaceutical design, 17 (16), 16121632

Dig Liver Dis 36:337341
